TMEFF2 and central nervous system cancer: We have found that TMEFF2 hypermethylation is associated with non-Proneural subtypesof GBMs, in contrast with G-CIMP methylation and IDH1 mutation status, which areassociated with the Proneural subtype and lower-grade gliomas.